BioRestorative Therapies, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioRestorative Therapies, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • BioRestorative Therapies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $31.8M, a 14.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $31.8M +$4.06M +14.6% Dec 31, 2023 10-K/A 2024-06-11
Q4 2022 $27.8M +$5.82M +26.5% Dec 31, 2022 10-K/A 2024-06-11
Q4 2021 $22M +$7.86M +55.7% Dec 31, 2021 10-K 2023-03-27
Q4 2020 $14.1M +$2.09M +17.4% Dec 31, 2020 10-K 2022-03-30
Q4 2019 $12M +$3.83M +46.9% Dec 31, 2019 10-K 2021-04-30
Q4 2018 $8.18M +$2.79M +51.8% Dec 31, 2018 10-K 2021-03-18
Q4 2017 $5.39M -$1.29M -19.3% Dec 31, 2017 10-K 2019-03-29
Q4 2016 $6.68M +$3.27M +96% Dec 31, 2016 10-K 2018-04-02
Q4 2015 $3.41M -$2.92M -46.2% Dec 31, 2015 10-K 2017-03-22
Q4 2014 $6.33M -$43.5K -0.68% Dec 31, 2014 10-K 2016-03-30
Q4 2013 $6.37M +$1.63M +34.4% Dec 31, 2013 10-K 2015-03-31
Q4 2012 $4.74M Dec 31, 2012 10-K 2014-04-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.